Katalin Karikó
卡塔林·卡里科
Pioneer of mRNA Technology
“I thought of leaving science many times, but I always went back to the bench.”
“我多次想过离开科学，但总是回到了实验台前。”
— From interviews, The Guardian, 2021
Biography
Katalin Karikó spent decades researching mRNA technology despite repeated rejections, demotions, and funding denials. Her persistence paid off spectacularly when her foundational work on modified mRNA enabled the rapid development of the Pfizer-BioNTech and Moderna COVID-19 vaccines, which have been administered billions of times worldwide. She received the 2023 Nobel Prize in Physiology or Medicine, vindicating decades of underfunded, underappreciated research.
卡塔林·卡里科尽管一再遭到拒绝、降职和资金否决，仍花了数十年研究mRNA技术。她的坚持获得了惊人的回报——她在修饰mRNA方面的基础工作使辉瑞-BioNTech和Moderna新冠疫苗得以快速开发，这些疫苗已在全球接种数十亿次。她获得了2023年诺贝尔生理学或医学奖，证明了数十年来资金不足、不受重视的研究的价值。
Key Achievements
Nobel Prize in Physiology or Medicine (2023)
诺贝尔生理学或医学奖（2023年）
Foundational mRNA research enabled COVID-19 vaccines
基础mRNA研究使新冠疫苗成为可能
Vaccines administered billions of times worldwide
疫苗在全球接种数十亿次
References & Citations
- Wikipedia: Katalin Karikó — https://en.wikipedia.org/wiki/Katalin_Karik%C3%B3
- Nobel Prize: Katalin Karikó — https://www.nobelprize.org/prizes/medicine/2023/kariko/
